New HDL-cholesterol reagent formulation reduces interference from samples with abnormal proteins

Clinica Chimica Acta

Volumn 374, Issue 1-2, 2006, Pages 142-144

  Hoefner, Daniel M ^a  

^a LABORATORY CORPORATION OF AMERICA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; REAGENT;

BLOOD SAMPLING; CHEMICAL COMPOSITION; CHEMICAL STRUCTURE; DENSITY; DIAGNOSTIC PROCEDURE; HUMAN; ISCHEMIC HEART DISEASE; LABORATORY AUTOMATION; LETTER; LIPID ANALYSIS; METHODOLOGY; PRIORITY JOURNAL; PRODUCT DEVELOPMENT; RISK ASSESSMENT;

BLOOD PROTEINS; CHOLESTEROL, HDL; CLINICAL LABORATORY TECHNIQUES; COLORIMETRY; DIAGNOSTIC ERRORS; FALSE POSITIVE REACTIONS; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS;

EID: 33750014045     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2006.03.026     Document Type: Letter

References (12)

1. Ashen M.D., and Blumenthal R.S. Clinical practice. Low HDL cholesterol levels. N Engl J Med 353 (2005) 1252-1260
2. Warnick G.R., Nauck M., and Rifai N. Evolution of methods for measurement of HDL-cholesterol: from ultracentrifugation to homogeneous assays. Clin Chem 47 (2001) 1579-1596
3. Sugiuchi H. History of development and technical details of the homogeneous assays for HDL and LDL cholesterol. Fats of Life (AACC Lipoproteins and Vascular Diseases Division Newsletter) vol. 9 (2005) 4-11
4. Berth M., and Delanghe J. Protein precipitation as a possible important pitfall in the clinical chemistry analysis of blood samples containing monoclonal immunoglobulins: 2 case reports and a review of the literature. Acta Clin Belg 59 (2004) 263-273
5. Kimberly M.M., Leary E.T., Cole T.G., and Waymack P.P. Selection, Validation, Standardization, and Performance of a Designated Comparison Method for HDL-cholesterol for Use in the Cholesterol Reference Method Laboratory Network. Clin Chem 45 (1999) 1803-1812
6. Kadri N., Douville P., and Lachance P. Monoclonal paraprotein may interfere with the Roche direct HDL-C Plus assay. Clin Chem 48 (2002) 964
7. Bakker A.J., Zijlstra A., and Leemhuis M.P. False negative results in the Roche assay for HDL-cholesterol. Ann Clin Biochem 40 (2003) 572-575
8. Roberts W.L., Leary E.T., Lambert T.L., Moulton L., and Goestch J.L. Falsely low direct HDL-cholesterol results in a patient with dysbetalipoproteinemia. Clin Chem 46 (2000) 560-562
9. Tsai L.Y., Tsai S.M., Lee S.C., and Liu S.F. Falsely low LDL-cholesterol concentrations and artifactual undetectable HDL-cholesterol measured by direct methods in a patient with monoclonal paraprotein. Clin Chim Acta 358 (2005) 192-195
10. Baca A., Haber R.J., Sujishi K., Frost P.H., and Ng V.L. Artifactual undetectable HDL-cholesterol with the Beckman Synchron LX and Vitros 950 assays temporally associated with a paraprotein. Clin Chem 50 (2004) 255-256
11. De Milito A., Nilsson A., Titanji K., et al. Mechanisms of hypergammaglobulinemia and impaired antigen-specific humoral immunity in HIV-1 infection. Blood 103 (2004) 2180-2186
12. Zapico-Muñiz E., Jorba-Castany O., Bonet-Marqués R., and Ordoñez-Llanos J. A cause of falsely low HDL concentrations in HIV-infected patients: increased polyclonal serum immunoglobulin. Clin Biochem 38 (2005) 46-49